Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 11.45% vs -8.15% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 130.74% vs -455.15% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 27.59% vs -15.42% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 46.27% vs -64.69% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Takeda Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 11.45% vs -8.15% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 10.23% vs -8.39% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 130.74% vs -455.15% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -8.87% vs 30.41% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 27.59% vs -15.42% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 10.53% vs -9.64% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 46.27% vs -64.69% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -40.42% vs 79.52% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






